• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Molecular pathobiological studies on the multi-functional SERPIN, protein C inhibitor-dependent diseases

Research Project

Project/Area Number 14370055
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Pathological medical chemistry
Research InstitutionMie University

Principal Investigator

SUZUKI Koji  Mie University, Faculty of Medicine, Professor, 医学部, 教授 (70077808)

Co-Investigator(Kenkyū-buntansha) ESTEBAN Gabazza  Mie University, Faculty of Medicine, Assistant Professor, 医学部, 助手 (00293770)
KAMADA Haruhiko  Mie University, Faculty of Medicine, Assistant Professor, 医学部, 助手 (00324509)
HAYASHI Tatsuya  Mie University, Faculty of Medicine, Lecturer, 医学部, 講師 (00242959)
WADA Hideo  Mie University, Faculty of Medicine, Associate Professor, 医学部, 助教授 (40158704)
Project Period (FY) 2002 – 2003
Project Status Completed (Fiscal Year 2003)
Budget Amount *help
¥13,700,000 (Direct Cost: ¥13,700,000)
Fiscal Year 2003: ¥6,400,000 (Direct Cost: ¥6,400,000)
Fiscal Year 2002: ¥7,300,000 (Direct Cost: ¥7,300,000)
Keywordsprotein C inhibitor / serpin / uPA / activated protein C / renal cell carcinoma / CpG methylation / transgenic mice / pro-inflammatory factor / SERPIN / 種特異的臓器発現 / HGFアクチベーター / 肝障害 / 肝再生
Research Abstract

Protein C inhibitor (PCI), a member of the SERPIN family, is produced in various human tissues, including the liver, kidney, and testis. In addition to inhibit the anticoagulant protein C pathway, PCI also inhibits urinary uPA, which is a well-known mediator of tumor cell invasion. (1) To clarify the biological significance of PCI in the kidney, we compared the expression of PCI between human renal cell carcinoma (RCC) tissue and non-tumor kidney tissue. The PCI level in RCC tissue was found to be significantly lower than in non-tumor kidney tissue, and expression of PCI mRNA was detected in normal renal proximal tubular epithelial cells, but not in RCC nor in an RCC cell line (Caki-1cells). Methylation of some CpG islands in the promoter region of PCI gene was detected from RCC cell lines, but not from non-tumor kidney cells. The in vitro invasiveness of Caki-1 cells transfected with a PCI expression vector was significantly decreased compared to mock-transfected Caki-1 cells. These f … More indings suggest that PCI regulates the invasive potential of RCC cells by inhibiting uPA secreted by these cells. (2) Moreover, we produced human PCI gene-transgenic (TG) mice and characterized the tissue distribution and biological functions of PCI expressed in the TG mice. Northern blot and immunohistochemical analyses showed that in the TG mice the human PCI is expressed not only in the reproductive organs such as testis, ovary and uterus, but also in the liver hepatocytes, renal epithelial cells, heart and brain; these tissue distribution of the PCI being similar to that in humans. The PCI expressed in the TG mice efficiently inhibited the anticoagulant and anti-inflammatory activities of the extraneously injected human activated protein C (APC) in the TG mice by forming a complex with APC. These findings demonstrate that human PCI gene TG mice are useful as experimental animal models to evaluate pathological significance of human PCI and also therapeutic effects of human APC in vivo. Less

Report

(3 results)
  • 2003 Annual Research Report   Final Research Report Summary
  • 2002 Annual Research Report
  • Research Products

    (31 results)

All Other

All Publications (31 results)

  • [Publications] Suzuki, K., Gabazza, E.C., et al.: "Protective role of activated protein C in lung and airway remodeling."Crit.Care Med.. 32. 262-265 (2004)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Hayashi, T., Suzuki, K., et al.: "Characterization of mice transgenic for a human protein C inhibitor gene, useful as in vivo models for the evaluation of the therapeutic effects of humanactivated protein C."J.Thromb. Haemost.. 2. 949-961 (2004)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Wakita, T., Suzuki, K., et al.: "Regulation of carcinoma cell invasion by protein C inhibitor whose expression is decreased in renal cell carcinoma."Int.J.Cancer. 108. 516-523 (2004)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Yuda, H., Suzuki, K., et al.: "Activated protein C inhibits bronchial hyperresponsiveness and Th2 cytokine expression in the mouse."Blood. 103. 2196-2204 (2004)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Takeya, H., Suzuki.K., et al.: "Synergistic effect of sphingosine 1-phosphate on thrombin-induced tissue factor expression in endothelial cells."Blood. 102. 1696-1700 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Fujimoto, H., Suzuki, K., et al.: "Thrombin-activateble fibrinolysis inhibitor and protein C inhibitor in interstitial lung disease."Am.J.Respir.Crit.Care Med.. 167. 1687-1694 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Shimizu, S., Suzuki, K., et al.: "Activated protein C inhibits the expression of platelet-derived growth factor in the lung."Am.J.Respir.Crit.Care Med.. 167. 1416-1426 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Gabazza, E.C., Suzuki, K., et al.: "Adenosine inhibits thrombin-induced expression of tissue factor on endothelial cells by a nitric oxide-mediated mechanism."Clin.Science. 102. 167-175 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] 鈴木 宏治 (鈴木宏治, 一瀬白帝 編): "図説 分子病態学 3版"中外医学社 東京. 501 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Suzuki, K., et al.: "Protective role of activated protein C in lung and airway remodeling."Clit. Care Med.. 32. 262-265 (2004)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Hayashi, T., et al.: "Characterization of a novel human protein C inhibitor gene transgenic mouse useful for studying the role of PCI in physiological and pathological condition."J. Thromb. Haemost.. 2. 949-961 (2004)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Wakita, T., et al.: "Regulation of carcinoma cell invasion by protein C inhibitor whose expression is decreased in renal cell carcinoma."Int. J. Cancer. 108. 516-523 (2004)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Yuda, H., et al.: "Activated protein C inhibits bronchial hyper-responsiveness and The cytokine expression in the mouse."Blood. 103. 2196-2204 (2004)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Takeya, H., et al.: "Synergistic effect of sphingosine 1-phosphate on thrombin-induced tissuefactor expression in endothelial cells."Blood. 102. 1693-1700 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Fujimoto, H., et al.: "Thrombin-activatable fibrinolysis inhibitor and protein C inhibitor in interstitial lung disease."Am. J. Respir. Crit. Care Med.. 167. 1687-1694 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Shimizu, S., et al.: "Activated protein C inhibits the expression of platelet-derived growth factor in the lung."Am. J. Respir. Crit. Care Med.. 167. 1416-1426 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Gabazza, E.C., et al.: "Adenosine inhibits thrombin-induced expression of tissue factor on endothelial cells by a nitric oxide-mediated mechanism."Clin. Science. 102. 167-175 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Takeya, H., Suzuki, K., et al.: "Synergistic effect of sphingosine 1-phosphate on thrombin-induced tissue factor expression in endothelial cells."Blood. 102. 1693-1700 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Wakita, T., Suzuki, K., et al.: "Regulation of carcinoma cell invasion by protein C inhibitor whose expression is decreased in renal cell carcinoma."Int.J.Cancer. 108. 516-523 (2004)

    • Related Report
      2003 Annual Research Report
  • [Publications] Yuda, H., Suzuki, K., et al.: "Activated protein C inhibits bronchial hyperresponsiveness and Th2 cytokine expression in the mouse."Blood. (In Press). (2004)

    • Related Report
      2003 Annual Research Report
  • [Publications] Hataji, O., Suzuki, K., et al.: "Increased circulating levels of thrombin-activatable fibrinolysis inhibitor in lung cancer patients."Am.J.Haematol.. (In Press). (2004)

    • Related Report
      2003 Annual Research Report
  • [Publications] Hayashi, T., Suzuki, K., et al.: "Characterization of mice transgenic for a human protein C inhibitor gene, useful as in vivo models for the evaluation of the therapeutic effects of human activated protein C."J.Thromb.Haemost.. (In Press). (2004)

    • Related Report
      2003 Annual Research Report
  • [Publications] Suzuki, K., Gabazza, E.C., et al.: "Protective role of activated protein C in lung and airway remodeling."Crit.Care Med.. (In Press). (2004)

    • Related Report
      2003 Annual Research Report
  • [Publications] 鈴木 宏治(鈴木宏治, 一瀬白帝 編): "図説 分子病態学 3版"中外医学社 東京. 501 (2004)

    • Related Report
      2003 Annual Research Report
  • [Publications] Hori Y, Suzuki, K., et al.: "Insulin resistance is associated with increased circulating level of thrombin-activatable fibrinolysis inhibitor in type 2 diabetic patients"J. Clin. Endoc. Metabol.. 87. 660-665 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Hataji, O., Suzuki, K., et al.: "Activation of protein C pathway in the airways"Lung. 180. 47-59 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Gabazza, E.C., Suzuki, K., et al.: "Adenosine inhibits thrombin-induced expression of tissue factor on endothelial cells by a nitric oxide-mediated mechanism"Clin. Science. 102. 167-175 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Iida, T., Mine, S., Suzuki, K., et al.: "Hypoxia-inducible factor-1a induces cell cycle arrest of endothelial cells"Genes to Cells. 7. 143-149 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Kume, M., Suzuki, K., et al.: "Bacterial lipoplysaccharide decreases thrombomodulin expression on sinusoidal endothelial cells of rats, which may induce liver dysfunction via microthrombus formation in the sinusoids"J. Hepatol.. 38. 9-17 (2003)

    • Related Report
      2002 Annual Research Report
  • [Publications] Shimizu, S., Suzuki, K., et al.: "The Natural anticoagulant activated protein C inhibits the expression of platelet-derived growth factor in the lung"Am. J. Respir. Crit. Care Med.. (In press). (2003)

    • Related Report
      2002 Annual Research Report
  • [Publications] 鈴木 宏治(大内和雄 編集): "廣川タンパク質化学 第7巻 制御タンパク質-インヒビター"廣川書店 東京. 196 (2002)

    • Related Report
      2002 Annual Research Report

URL: 

Published: 2002-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi